1. Performance of Xpert HPV on Self-collected Vaginal Samples for Cervical Cancer Screening Among Women in South Africa
- Author
-
Scott Campbell, Rosalind Boa, Ana I. Tergas, Rakiya Saidu, Lynette Denny, Jennifer Moodley, David H. Persing, Cecilia Svanholm-Barrie, Wei-Yann Tsai, Louise Kuhn, and Thomas C. Wright
- Subjects
Adult ,medicine.medical_specialty ,Referral ,Uterine Cervical Neoplasms ,Screening and Treatment ,HIV Infections ,Cervical cancer screening ,Cervical intraepithelial neoplasia ,South Africa ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Humans ,Medicine ,Human papillomavirus ,Papillomaviridae ,Early Detection of Cancer ,Vaginal Smears ,030219 obstetrics & reproductive medicine ,Hpv types ,business.industry ,Obstetrics ,Papillomavirus Infections ,virus diseases ,Obstetrics and Gynecology ,General Medicine ,Middle Aged ,medicine.disease ,Colposcopy ,030220 oncology & carcinogenesis ,Female ,Test performance ,business - Abstract
OBJECTIVES: Self-sampling may increase access to cervical cancer screening in low-resource settings. Using Xpert HPV, we compared test performance of self- and clinician-collected samples in HIV-positive and HIV-negative women in South Africa. MATERIALS AND METHODS: Three hundred thirty HIV-positive and 375 HIV-negative women in the screening group and 202 HIV-negative and 200 HIV-positive women in the referral group, aged 30–65 years, participated in the study. All women self-collected a vaginal sample, and then, a cervical sample was collected by a clinician (both tested using Xpert HPV), followed by colposcopic examination and collection of histologic specimens. RESULTS: There was good agreement between self- and clinician-collected samples for detection of any high-risk human papillomavirus (HPV, κ = 0.72 [95% CI = 0.669–0.771]). Prevalence of HPV and sensitivity of the test to detect cervical intraepithelial neoplasia 2+ was similar in self- and clinician-collected samples. Specificity was lower in self-collected than in clinician-collected samples in both HIV-negative (self: 77.5% [95% CI = 72.8–81.8] vs clinician: 86.9% [95% CI = 82.9–90.2]) and HIV-positive (self: 44.0% [95% CI = 38.0–50.1] vs clinician: 59.7% [95% CI = 53.6–65.6]) women. Restricting the definition of screen-positive to 3 of 5 channels on HPV Xpert improved specificity in both HIV-negative (self: 83.2% [95% CI = 78.8–87.0] vs clinician: 89.7% [95% CI = 86.1–92.7]) and HIV-positive (self: 54.2% [95% CI = 48.1–60.2] vs clinician: 67.4% [95% CI = 61.5–72.9]) women. CONCLUSIONS: The self-collected sample had good agreement with the clinician-collected sample for the detection of HPV, and restricting the HPV types may improve the specificity in HIV-positive women.
- Published
- 2020
- Full Text
- View/download PDF